Literature DB >> 2973311

GM2-gangliosidosis B1 variant: a wide geographic and ethnic distribution of the specific beta-hexosaminidase alpha chain mutation originally identified in a Puerto Rican patient.

A Tanaka1, K Ohno, K Suzuki.   

Abstract

A point mutation within exon 5 of beta-hexosaminidase alpha chain gene was identified earlier in a Puerto Rican patient with GM2-gangliosidosis B1 variant (the DN-allele) [K. Ohno and K. Suzuki: J. Neurochem. 50:316-318, 1988]. Oligonucleotide probes designed to detect either the normal or the DN-allele showed that four additional patients carried the same mutation. These patients were of Italian, French, Spanish, and English/Italian/Hungarian origin. Three of them, as well as our original patient, were compound heterozygotes with positive signals for both the mutant and normal probes, while the Spanish patient was positive only for the DN-allele. A patient from Czechoslovakia was negative for the DN-allele. Thus, the specific mutation originally found in the Puerto Rican patient has a surprisingly wide geographic and ethnic distribution. This mutation can account for the B1 variant phenotype in five of the six B1 variant patients so far examined.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973311     DOI: 10.1016/s0006-291x(88)80945-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Structural basis of the GM2 gangliosidosis B variant.

Authors:  Fumiko Matsuzawa; Sei-ichi Aikawa; Hitoshi Sakuraba; Hoang Thi Ngoc Lan; Akemi Tanaka; Kousaku Ohno; Yuko Sugimoto; Haruaki Ninomiya; Hirofumi Doi
Journal:  J Hum Genet       Date:  2003-10-24       Impact factor: 3.172

2.  Molecular genetics of Tay-Sachs disease in Japan.

Authors:  A Tanaka; H Sakazaki; H Murakami; G Isshiki; K Suzuki
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

3.  Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.

Authors:  Brian L Mark; Don J Mahuran; Maia M Cherney; Dalian Zhao; Spencer Knapp; Michael N G James
Journal:  J Mol Biol       Date:  2003-04-11       Impact factor: 5.469

4.  GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients.

Authors:  A Tanaka; K Ohno; K Sandhoff; I Maire; E H Kolodny; A Brown; K Suzuki
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

5.  A new point mutation in the beta-hexosaminidase alpha subunit gene responsible for infantile Tay-Sachs disease in a non-Jewish Caucasian patient (a Kpn mutant).

Authors:  A Tanaka; H H Punnett; K Suzuki
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

6.  Six novel deleterious and three neutral mutations in the gene encoding the alpha-subunit of hexosaminidase A in non-Jewish individuals.

Authors:  E H Mules; S Hayflick; C S Miller; L W Reynolds; G H Thomas
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

7.  GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene mutations in 11 patients from a defined region in Portugal.

Authors:  M R dos Santos; A Tanaka; M C sá Miranda; M G Ribeiro; M Maia; K Suzuki
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

8.  Neuroradiological findings in GM2 gangliosidosis variant B1.

Authors:  Shahina Bano; Akhila Prasad; Sachchida Nand Yadav; Vikas Chaudhary; Umesh Chandra Garga
Journal:  J Pediatr Neurosci       Date:  2011-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.